Literature DB >> 3163264

t(10;17) as the sole chromosome change in a uterine leiomyosarcoma.

P Dal Cin1, L Boghosian, K Crickard, A A Sandberg.   

Abstract

A cytogenetic analysis in a primary uterine leiomyosarcoma revealed a t(10;17) as the only chromosome change. This finding is discussed in relation to cytogenetic analyses on uterine leiomyomas and leiomyosarcomas reported previously.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3163264     DOI: 10.1016/0165-4608(88)90289-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

1.  DNA copy number changes in development and progression in leiomyosarcomas of soft tissues.

Authors:  W El-Rifai; M Sarlomo-Rikala; S Knuutila; M Miettinen
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

2.  Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma.

Authors:  B J Quade; A P Pinto; D R Howard; W A Peters; C P Crum
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

3.  Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.

Authors:  Abbas Agaimy; Blaise A Clarke; David L Kolin; Cheng-Han Lee; Jen-Chieh Lee; W Glenn McCluggage; Patrik Pöschke; Robert Stoehr; David Swanson; Gulisa Turashvili; Matthias W Beckmann; Arndt Hartmann; Cristina R Antonescu; Brendan C Dickson
Journal:  Am J Surg Pathol       Date:  2022-05-17       Impact factor: 6.298

4.  Chromosomal abnormalities in leiomyosarcomas.

Authors:  C Sreekantaiah; J R Davis; A A Sandberg
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

5.  Leiomyoma with KAT6B-KANSL1 fusion: case report of a rapidly enlarging uterine mass in a postmenopausal woman.

Authors:  Alessandra J Ainsworth; Nooshin K Dashti; Taofic Mounajjed; Karen J Fritchie; Jaime Davila; Rohini Mopuri; Rory A Jackson; Kevin C Halling; Jamie N Bakkum-Gamez; J Kenneth Schoolmeester
Journal:  Diagn Pathol       Date:  2019-04-25       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.